Caxton Associates LP
- SEC CIK
- 0000872573
- Latest filing
- Feb 14, 2025
BMY holding history
Bristol Myers Squibb Co in every 13F filed by Caxton Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BMY overviewAll 13F holders of BMYFull Q4 2024 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −27,369−100.0% | Sold out | Holders |
| Q1 2024 | 27,369 | $1.48M | 0.1% | +1,430+5.5% | Added | Holders |
| Q4 2023 | 25,939 | $1.33M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 25,939 | $1.51M | 0.2% | +14,204+121.0% | Added | Holders |
| Q2 2023 | 11,735 | $750.5K | 0.1% | +1,771+17.8% | Added | Holders |
| Q1 2023 | 9,964 | $690.6K | 0.1% | −15,940−61.5% | Reduced | Holders |
| Q4 2022 | 25,904 | $1.86M | 0.1% | +25,904 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −8,082−100.0% | Sold out | Holders |
| Q2 2022 | 8,082 | $622.0K | 0.1% | +8,082 | New | Holders |